CHINA PHARMA HOLDINGS, INC. (CPHI) Return on equity 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14.0%FY2025 · since FY2016: -15.6% → -14.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.0% | +47.1 pp |
| FY2024 | -61.1% | -19.8 pp |
| FY2023 | -41.3% | +51.3 pp |
| FY2022 | -92.6% | -36.1 pp |
| FY2021 | -56.5% | -20.7 pp |
| FY2020 | -35.8% | +188.3 pp |
| FY2019 | -224.1% | -188.5 pp |
| FY2018 | -35.6% | +9.2 pp |
| FY2017 | -44.8% | -29.2 pp |
| FY2016 | -15.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice